Skip to main content

Table 3 Postoperative laboratory inflammatory indexes

From: Effect of preoperative immunonutrition on postoperative short-term clinical outcomes in patients with gastric cancer cachexia: a prospective randomized controlled trial

 

IN(n = 56)

SEN(n = 56)

P

WBC(*109/L)

 Baseline

 PrOD

 POD1

 POD3

 POD5

6.06 ± 1.30

5.46 ± 1.27

9.19 ± 2.64

6.81 ± 1.62

6.10 ± 1.45

6.46 ± 1.54

6.15 ± 1.55

10.40 ± 2.76

8.61 ± 2.88

6.78 ± 2.64

0.137

0.011

0.019

<0.001

0.034

CRP(mg/L)

 Baseline

 PrOD

 POD1

 POD3

 POD5

2.44(1.06–4.76)

1.19(0.51–3.05)

18.06(9.21–38.99)

65.83(46.40–92.30)

33.46(20.26–57.67)

2.25(0.94–5.35)

2.66(1.07–7.18)

35.99(15.10-66.23)

80.03(55.52-122.34)

39.18(25.78–70.41)

0.798

0.005

0.003

0.042

0.295

PCT(ng/mL)

 Baseline

 PrOD

 POD1

 POD3

 POD5

0.05(0.03–0.06)

0.04(0.03–0.06)

0.09(0.07–0.15)

0.12(0.08–0.18)

0.10(0.07–0.20)

0.05(0.02–0.06)

0.05(0.04–0.07)

0.08(0.05–0.12)

0.11(0.07–0.18)

0.09(0.06–0.15)

0.328

0.151

0.099

0.532

0.474

IL-1(pg/mL)

 Baseline

 PrOD

 POD3

1.70(1.55–5.78)

1.55(1.55–2.52)

1.55(1.55–1.79)

1.55(1.55–4.40)

1.55(1.55–1.79)

1.55(1.55–1.79)

0.530

0.506

0.839

IL-6(pg/mL)

 Baseline

 PrOD

 POD3

1.74(1.74–3.66)

1.74(1.74–3.15)

18.06(1.74–63.86)

1.74(1.74–3.99)

1.74(1.74–3.99)

45.97(9.43–69.97)

0.519

0.448

0.048

IL-8(pg/mL)

 Baseline

 PrOD

 POD3

1.89(1.89–43.46)

1.89(1.89–38.20)

1.89(1.89–5.32)

1.89(1.89–43.46)

1.89(1.89–43.46)

1.89(1.89–17.17)

0.621

0.921

0.925

IFN-γ(pg/mL)

 Baseline

 PrOD

 POD3

1.78(1.78-3.00)

1.78(1.78–3.02)

1.78(1.78–2.13)

2.08(1.78–3.20)

2.24(1.78–3.45)

1.78(1.78–1.78)

0.651

0.401

0.465

TNF-α(pg/mL)

 Baseline

 PrOD

 POD3

2.03(2.03–2.03)

2.03(2.03–2.03)

2.03(2.03–2.03)

2.03(2.03–2.03)

2.03(2.03–2.03)

2.03(2.03–2.03)

0.504

0.750

0.949

  1. WBC, white blood cell count; CRP, C-reactive protein; PCT, procalcitonin; IL-1, 6, 8, interleukin-1, 6, 8 ; IFN-γ, interferon-gamma; TNF-α, tumor necrosis factor-alpha